Related umbilical cord blood transplantation in patients with thalassemia and sickle cell disease

Blood

Volumn 101, Issue 6, 2003, Pages 2137-2143

  Locatelli, Franco ^a   Rocha, Vanderson ^b   Reed, William ^b   Bernaudin, Françoise ^b   Ertem, Mehmet ^b   Grafakos, Stelios ^b   Brichard, Benedicte ^b   Li, Xiaxin ^b   Nagler, Arnon ^b   Giorgiani, Giovanna ^b   Haut, Paul R ^b   Brochstein, Joel A ^b   Nugent, Diane J ^b   Blatt, Julie ^b   Woodard, Paul ^b   Kurtzberg, Joanne ^b   Rubin, Charles M ^b   Miniero, Roberto ^b   Lutz, Patrick ^b   Raja, Thirumalairaj ^b   Roberts, Irene ^b   Will, Andrew M ^b   Yaniv, Isaac ^b   Vermylen, Christiane ^b   Tannoia, Nunzia ^b   Garnier, Federico ^b   Ionescu, Irina ^b   Walters, Mark C ^b   Lubin, Bertram H ^b   Gluckman, Eliane ^b   more..

^a UNIVERSITY OF PAVIA   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; FLUDARABINE; LYMPHOCYTE ANTIBODY; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; STEROID; TACROLIMUS; THIOTEPA; THYMOCYTE ANTIBODY;

ADOLESCENT; ARTICLE; BONE MARROW TRANSPLANTATION; CHILD; CLINICAL ARTICLE; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MALE; PRIORITY JOURNAL; PROPHYLAXIS; RISK ASSESSMENT; SICKLE CELL ANEMIA; SURVIVAL; THALASSEMIA; TREATMENT FAILURE; UMBILICAL CORD;

EID: 0037443543     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2002-07-2090     Document Type: Article

References (33)

1. Lucarelli G, Galimberti M, Giardini C, et al. Bone marrow transplantation in thalassemia. The experience of Pesaro. Ann N Y Acad Sci. 1998;850:270-275.
2. Thomas ED, Buckner CD, Sanders JE, et al. Marrow transplantation for thalassemia. Lancet. 1982;2:227-229.
3. Lucarelli G, Galimberti M, Polchi P, et al. Marrow transplantation in patients with thalassemia responsive to iron chelation therapy. N Engl J Med. 1993;329:840-844.
4. Lucarelli G, Galimberti M, Polchi P, et al. Bone marrow transplantation in patients with thalassemia. N Engl J Med. 1990;322:417-421.
5. Lucarelli G, Clift RA, Galimberti M, et al. Marrow transplantation for patients with thalassemia: results in class 3 patients. Blood. 1996;87:2082-2088.
6. Lucarelli G, Clift RA, Galimberti M, et al. Bone marrow transplantation in adult thalassemic patients. Blood. 1999;93:1164-1167.
7. Johnson FL, Look AT, Gockerman J, Ruggiero MR, Dalla-Pozza L, Billings FT. Bone marrow transplantation in a patient with sickle cell anemia. N Engl J Med. 1984;311:780-783.
8. Walters MC, Patience M, Leisenring W, et al. Bone marrow transplantation for sickle cell disease. N Engl J Med. 1996;335:369-376.
9. Vermylen C, Robles EF, Ninane J, Cornu G. Bone marrow transplantation in five children with sickle cell anemia. Lancet. 1988;1:1427-1428.
10. Vermylen C, Cornu G, Ferster A, et al. Haematopoietic stem cell transplantation for sickle cell anaemia: the first 50 patients transplanted in Belgium. Bone Marrow Transplant. 1998;22:1-6.
11. Bernaudin F, Soulliet G, Vannier JP, et al. Bone marrow transplantation (BMT) in 14 children with severe sickle cell disease (SCD): the French expedence. Bone Marrow Transplant. 1993;12(suppl 1):118-121.
12. Gaziev D, Polchi P, Galimberti M, et al. Graft-versus-host disease after bone marrow transplantation for thalassemia: an analysis of incidence and risk factors. Transplantation. 1997;63:854-860.
13. Sullivan KM, Parkman R, Walters MC. Bone marrow transplantation for non-malignant disease. American Society of Hematology Education Program Book. 2000;319-338.
14. Wagner JE, Kernan NA, Steinbuch M, Broxmeyer HE, Gluckman E. Allogeneic sibling umbilical cord blood transplantation in forty-four children with malignant and non-malignant disease. Lancet. 1995;46:214-219.
15. Gluckman E, Rocha V, Boyer-Chammard A, et al. Outcome of cord-blood transplantation from related and unrelated donors. Eurocord Transplant Group and the European Blood and Marrow Transplantation Group. N Engl J Med. 1997;337:373-381.
16. Locatelli F, Rocha V, Chastang C, et al. Factors associated with outcome after cord blood transplantation in children with acute leukemia. Blood. 1999;93:3662-3671.
17. Rocha V, Wagner-JE, Sobocinski KA, et al. Graft-versus-host disease in children who have received a cord-blood or bone marrow transplant from an HLA-identical sibling. Eurocord and International Bone Marrow Transplant Registry Working Committee on Alternative Donor and Stem Cell Sources. N Engl J Med. 2000;342:1846-1854.
18. Lucarelli G, Giardini C, Angelucci E. Bone marrow transplantation in thalassemia. In: Winter JN, ed. Blood Stem Cell Transplantation. Boston, MA: Kluwer Academic; 1997:305-315.
19. Rubinstein P, Dobrila L, Rosenfield RE, et al. Processing and cryopreservation of placental-umbilical cord blood for unrelated marrow reconstitution. Proc Natl Acad Sci U S A. 1995;92:10119-10122.
20. Thomas ED, Storb R, Clift RA, et al. Bonemarrow transplantation (first of two parts). N Engl J Med. 1975;292:832-843.
21. Shulman HM, Sullivan KM, Weiden PL, et al. Chronic graft-versus-host syndrome in man. A long-term clinico-pathologic study of 20 Seattle patients. Am J Med. 1980;69:204-217.
22. Issagrisil S, Visuthisakchai S, Suvatte V, et al. Brief report: transplantation of cord-blood stem cells into a patient with severe thalassemia. N Engl J Med. 1995;332:367-369.
23. Lau YL, Ma ES, Ha SY, et al. Sibling HLA-matched cord blood transplant for beta-thalassemia: report of two cases, expression of fetal hemoglobin and review of the literature. J Pediatr Hematol Oncol. 1998;20:477-481.
24. Brichard B, Vermylen C, Ninane J, Cornu G. Persistence of fetal hemoglobin production after successful transplantation of cord blood stem cells in a patient with sickle cell anemia. J Pediatr. 1996;128:241-243.
25. Atkinson K. Chronic graft-versus-host disease. Bone Marrow Transplant. 1990;5:69-82.
26. Locatelli F, Bruno B, Zecca M, et al. Cyclosporin A and short-term methotrexate versus cyclosporine A as graft versus host disease prophylaxis in patients with severe aplastic anemia given allogeneic bone marrow transplantation from HLA-identical sibling: results of a GITMO/EBMT randomized trial. Blood. 2000;96:1690-1697.
27. Terenzi A, Lubin I, Lapidot T, et al. Enhancement of T cell-depleted bone marrow allografts in mice by thiotepa. Transplantation. 1990;50:717-720.
28. Andreani M, Manna M, Lucarelli G, et al. Persistence of mixed chimerism in patients transplanted for the treatment of thalassemia. Blood. 1996;87:3494-3499.
29. Hill RS, Petersen FB, Storb R, et al. Mixed hematologic chimerism after allogeneic marrow transplantation for severe aplastic anemia is associated with a higher risk of graft rejection and a lessened incidence of acute graft-versus-host disease. Blood. 1986;67:811-816.
30. Lannone R, Luznik L, Engstrom LW, et al. Effects of mixed hematopoietic chimerism in a mouse model of bone marrow transplantation for sickle cell anemia. Blood. 2001;97:3960-3965.
31. Wekerle T, Sykes M. Mixed hematopoietic chimerism as an approach for the induction of transplantation tolerance. Transplantation. 1999;68:459-467.
32. Sykes M, Eisenthal A, Sachs DH. Mechanism of protection from graft-versus-host disease in murine mixed allogeneic chimeras, I: development of a null cell population suppressive of cell-mediated lympholysis responses and derived from the syngeneic bone marrow component. J Immunol. 1988;140:2903-2911.
33. Burgio GR, Locatelli F. Ethics of creating programmed stem cell donors. Lancet. 2000;356:1868-1869.